KALLYOPE
Live / Registered — Registered (as of 04 Oct 2022)
What this means for you
Registered since 04 Oct 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88242123
- Registration number
- 6866593
- Mark type
- Stylized text
- Filed
- 26 Dec 2018
- Published for opposition
- 08 Oct 2019
- Registered
- 04 Oct 2022
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of gastrointestinal diseases, metabolic diseases, microbiome related conditions, and neurological diseases and disorders, and any disease or disorder associated with intestinal permeability; biochemicals for in vitro and in vivo scientific or research use; ; Active chemical ingredients for scientific or research use in the manufacture of pharmaceuticals for the treatment of gastrointestinal diseases, metabolic diseases, microbiome related conditions, and neurological diseases and disorders, and any disease or disorder associated with intestinal permeability
- Class 005 — Pharmaceuticals: pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, metabolic diseases, microbiome-related conditions, neurological diseases and disorders, and diseases and disorders associated with intestinal permeability ; pharmaceutical preparations and substances for treatment of diseases related to the gut-brain axis, gut-brain circuits and gut-restricted and gut-targeted molecules
- Class 042 — Scientific and technological services: medical and scientific research in the fields of gastrointestinal diseases, metabolic diseases, microbiome-related conditions, neurological diseases and disorders, and diseases and disorders associated with intestinal permeability; scientific and medical research and development; biological research and development; bacteriological research and development; pharmaceutical scientific research and development; pharmaceutical new product research and development for others; scientific chemical, biochemical, biotechnological, biological and bacteriological research and analysis; providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; medical and scientific research in the fields of diseases of the gut-brain axis, gut-brain circuits and gut-restricted and gut-targeted molecules
Owner
- Kallyope, Inc., New York, NY, US
- Kallyope, Inc., New York, NY, US
- Kallyope, Inc., New York, NY, US
Prosecution history
- 04 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 30 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Jul 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Jul 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Jul 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 01 Feb 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Feb 2022 — NON-FINAL ACTION E-MAILED
- 01 Feb 2022 — SU - NON-FINAL ACTION - WRITTEN
- 04 Jan 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Dec 2021 — USE AMENDMENT FILED
- 04 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Dec 2021 — TEAS STATEMENT OF USE RECEIVED